Cyclic cell adhesion modulation compounds
AssigneeTanabe Seiyaku Co., Ltd.
InventorsThomas J. Lobl, Shiu-Lan Chiang, Pina M. Cardarelli
Life of this patent
Estimating the term…
Abstract
Cyclized integrin receptor antagonist compounds useful in modulating cell adhesion to integrin receptors, including adhesion related to fibronectin and/or fibronectin receptors, are disclosed. Methods for synthesizing, testing, formulating, and using the compounds as therapeutic agents are also disclosed.
Claims15
A compound of the formula ##STR54## and pharmaceutically acceptable salts thereof, wherein L.sup.1 and L.sup.2 are each, or are together, a residue of an amino acid, an amino acid analog or an amino acid mimetic having a functional group suitable for the formation of a cyclizing bridge between L.sup.1 and L.sup.2 ;
- Z is a cyclizing moiety or bond between L.sup.1 and L.sup.2 ;
- 1is optional and, where present, is selected from the group consisting of Leu, Sar, D-Nal, Tyr, Phe, Ile, Pro, Gly, Ala, Val, norLeu, norVal, .beta.-Ala, Trp, and (Ada -Ala;
- 2 is selected from the group consisting of Arg, homoArg and norArg.
- 4 is selected from Asp and, where 2 is norArg, Glu.
- 5 is optional and, where present, is selected from the group consisting of Ser, Thr, Tyr, Trp, Ala, Val, Phe ##STR55## wherein m is 2, 3 or 4;
- 6is optional and, where present, is selected from the group consisting Pro, 3-thioPro, 1,1-ACC, Dhp, Hyp, homoPro and Phe;
- X.sup.1 and Y.sup.1 are each optional and, where present, are independently selected from sequences of 1 to 4 D- or L-amino acids or amino acid analogs;
- X.sup.2 is an optional N.sup..alpha. -substituent selected from R'-(including hydrogen) and R'CO--;
- and
- Y.sup.2 is an optional carboxyl terminal substituent selected from the group consisting of --OR' (including hydroxy), --NR'.sub.2 (including --NH.sub.2 and --NHR'), --NHNH.sub.2 and --SR';
- and wherein each R' is individually a pharmaceutically suitable substituent group, preferably one selected from the group consisting of hydrogen, linear and branched, unsubstituted and substituted C.sub.1 -C.sub.8 lower alkyls, C.sub.2 -C.sub.8 alkenyls, C.sub.2 -C.sub.8 alkenyls, C.sub.2 -C.sub.8 alkynyls, C.sub.6 -C.sub.14 aryls, C.sub.7 -C.sub.14 alkaryls, C.sub.7 -C.sub.14 alkaryls and C.sub.3 -C.sub.14 cycloalkyls, and, in the case of --NR'.sub.2, from cyclized groups forming (in an attachment with the nitrogen atom) a 5-8 membered heterocyclic ring optionally containing oxygen, nitrogen or sulfur as a further ring heteroatom.
Dependencies are inferred from the claim text.